Ergoteles LLC Soleno Therapeutics Inc Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.41 - $0.91 $30,555 - $67,817
-74,525 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$0.8 - $1.12 $156,940 - $219,716
-196,175 Reduced 72.47%
74,525 $69,000
Q2 2021

Aug 12, 2021
BUY
$0.97 - $1.32 $262,579 - $357,324
270,700 New
270,700 $309,000

About SOLENO THERAPEUTICS INC

SLNO Quotes by TradingView
  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $362M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email